1,2,3-Trifluoro-4-nitrobenzene

1,2,3-Trifluoro-4-nitrobenzene (CAS 771-69-7) is an important pharmaceutical intermediate used as a starting reagent in the synthesis of ofloxacin and other third-generation quinolone antibacterial drugs; its biotransformation under methanogenic conditions has also been studied in semicontinuous and batch tests. Manufactured directly by Speranza Chemical Co., Ltd. to a chemical-grade specification meeting ChP, USP, EP, JP, IP, and Ph. Int. standards, it is distributed across North America, Central/South America, Western Europe, Eastern Europe, Australasia, Asia, the Middle East, and Africa.